COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2062: Articles 20611-20620  | Next

Quantifying superspreading for COVID-19 using Poisson mixture distributions
Kremer, C., Torneri, A., Boesmans, S., Meuwissen, H., Verdonschot, S., Vanden Driessche, K., Althaus, C. L., Faes, C., Hens, N.
10.1101/2020.11.27.20239657 — Posted: 2020-11-30
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Scuotto, F., Marra, R., Almeida, L. L. d., Soares, M. S. R., Silva, G. K., Paul, L. C., Fenelon Costa, G. D., Cirenza, C.
10.1101/2020.11.26.20239418 — Posted: 2020-11-30
The evolving worldwide dynamic state of the COVID-19 outbreak
Vilar, J. M. G., Saiz, L.
10.1101/2020.11.26.20239434 — Posted: 2020-11-30
Risk exposures, risk perceptions, negative attitudes toward general vaccination, and COVID-19 vaccine acceptance among college students in South Carolina
Qiao, S., Tam, C. C., Li, X.
10.1101/2020.11.26.20239483 — Posted: 2020-11-30
The impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia:A time-series analysis of primary care electronic health records covering about 5 million people.
Coma, E., Guiriguet, C., Mora, N., Marzo-Castillejo, M., Benitez, M., Mendez-Boo, L., Fina, F., Fabregas, M., Mercade, A., Medina, M.
10.1101/2020.11.26.20239202 — Posted: 2020-11-30
Characteristics of COVID-19 patients admitted to a tertiary care hospital in Pune, India, and cost-effective predictors of intensive care treatment requirement
Shukla, U. B., Shukla, S. R., Palve, S. B., Yeravdekar, R., Natarajan, V., Tiwari, P., Yajnik, C. S.
10.1101/2020.11.26.20239186 — Posted: 2020-11-30
Altered Smell and Taste: anosmia, parosmia and the long impact of Covid-19
Burges Watson, D. L., Campbell, M., Hopkins, C., Smith, B., Kelly, C., Deary, V.
10.1101/2020.11.26.20239152 — Posted: 2020-11-30
Design of COVID-19 Staged Alert Systems to Ensure Healthcare Capacity with Minimal Closures
Yang, H., Sürer, O., Duque, D., Morton, D., Singh, B., Fox, S., Pasco, R., Pierce, K., Rathouz, P., Du, Z., Pignone, M., Escott, M. E., Adler, S. I., Johnston, S. C., Meyers, L. A.
10.1101/2020.11.26.20152520 — Posted: 2020-11-30
Changing case fatality risk for COVID-19 over time in selected European countries
Becher, H., Olszewski, K., Wiegel, S., Mueller, O.
10.1101/2020.11.26.20239327 — Posted: 2020-11-30
What do we Know about smell and taste dysfunction by SARS-CoV-2.Predictive value of the Venezuelan Olfactory test and RT-PCR analysis in viral infection diagnosis
Pieruzzini, R., Ayala-Grosso, C., Navas, J. D. J., Rodriguez, W. C., Parra, N., Luque, E., Sanchez Gago, A., Gonzalez, S., Hagobian, A., Grullon, A., Diaz, K., Morales, M., De Jesus, M., Pena, S., Rodriguez, L., Pena, L., Asaro, A., Magris, M.
10.1101/2020.11.25.20238998 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).